trial · primary record
bortezomib
Multiple Myeloma and Plasma Cell Neoplasm
| Phase | Phase 2 |
|---|---|
| Status | COMPLETED |
| Sponsor | Unknown |
| Enrolment | 45 |
| Primary completion | 2014-04-21 |
| Primary endpoint | Number of Participants With Adverse Events |
| Registry ID | NCT00792142 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-02T15:47:23.801Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT00792142
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.